Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study

Abstract

sARF is common and males, older patients, and those with underlying medical conditions are at greatest risk. Although the majority of patients with sARF will die, most survivors will become independent from renal replacement therapy within a year.